Global pharma market expected to slow down in 2008

November 2007
Chemical Business;Nov2007, Vol. 21 Issue 11, p89
Trade Publication
The article presents an outlook for the global pharmaceutical market in 2008 amid declining drug treatment costs, pricing issues and loss of patent protection in blockbuster medicines. IMH Health predicts global pharmaceutical sales to expand to $735-745 billion in 2008, with sales growth in the U.S. and the five largest European markets expected to be around 4-5%. Companies manufacturing generic drugs are forecasted to grow by 14-15% to more than $70 billion.


Related Articles

  • Drug-patent loopholes cited for higher costs.  // New Hampshire Business Review;02/22/2002, Vol. 24 Issue 4, p31 

    Focuses on how loopholes in New Hampshire's drug-patent policy increase drug costs. Trends among drug companies in regard to drug patents; Effect on genetic drugs; Action taken by the local government in response to the matter.

  • Competencia y precios en el mercado farmacéutico mexicano. Molina-Salazar, Raúl E.; González-Marín, Eloy; Carbajal-de Nova, Carolina // Salud Pública de México;nov2008 Supplement, Vol. 50, pS496 

    The forms of market competition define prices. The pharmaceutical market contains submarkets with different levels of competition; on the one hand are the innovating products with patents, and on the other, generic products with or without trade names. Innovating medicines generally have...

  • Generics sales expected to soar in next 4 years.  // PharmacoEconomics & Outcomes News;5/20/2006, Issue 503, p27 

    The article reports on the expectation that the global market for generic drugs will increase over the next four years from 2006 according to the reports "The World Market for Prescription Generic Drugs." It attributes the possible increase to the anticipated expiration of the so-called...

  • Changing landscape drives generics. Mirasol, Feliza // ICIS Chemical Business Americas;4/9/2007, Vol. 271 Issue 14, p27 

    The article reports on the outlook for the generic drug industry. The author claims that a changing landscape will put more pressure on generic drug prices, which would force drug companies to strategize. Tommy Erdei of UBS Global Healthcare stresses the need for companies to proactively think...

  • Pharmaceutical and biotech product patents in India: doldrums or blissfulness? Chowdhury, Pritom; Khan, Siraj A; Dutta, Prafulla; Mahanta, Jagadish // Nature Biotechnology;Feb2014, Vol. 32 Issue 2, p133 

    The article offers information on the confusion situation of pharmaceutical and biotechnological product patents in India owing to uncertain application of patent law and pressure from generics. Topics discussed include issues related to inconsistent and inadequate gene patenting, increasing...

  • Thailand's pharmaceutical stand heightens international row. Sanders, Sol W. // East-Asia-Intel Reports;2/14/2007, p13 

    The article reports that the decision of Thailand to allow either the manufacture or import of generic versions of Abbott's human immunodeficiency virus (HIV) treatment Kaletra and Sanofi-Aventis' blood clot drug Plavix, heightens international debate over drug pricing. The U.S. has been...

  • FTC: Settlements delaying introduction of cheap drugs. Bridges, Andrew // Buffalo Law Journal;1/22/2007, Vol. 79 Issue 7, p14 

    The article reports on the appeal made by the U.S. Federal Trade Commission (FTC) to legislators to ban the settlements between drug companies that delay the introduction of cheaper drugs. Such agreements allow brand-name drug manufacturers to pay-off their generic competitors. As of September...

  • India Kicks the Habit. Singh, Seema // Newsweek (Pacific Edition);11/22/2004 (Pacific Edition), Vol. 144 Issue 21, p48 

    Examines the generic pharmaceutical industry in India. Success of generic drugs in the Indian market due to patent laws that do not protect drugs from replication; Passage of a new patent law that prevents drug copying by Indian manufacturers; Impact of the law on drug pricing and marketing in...

  • Regulatory & Healthcare News.  // PharmacoEconomics & Outcomes News;11/17/2007, Issue 541, p15 

    The article reports on the prediction of IMS Health that the growth of the global pharmaceutical market will slow in 2008. A growth rate of 5%-6% is predicted for 2008 compared to the growth rate of 6%-7% in 2007. The firm's 2008 Global Pharmaceutical Market and Therapy Forecast predicts falling...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics